nsRPLND Appears Safe, Effective in Low-Volume Metastatic Seminoma
Nerve-sparing retroperitoneal lymph node dissection appears safe and effective for patients with low-volume metastatic seminoma.
Nerve-sparing retroperitoneal lymph node dissection appears safe and effective for patients with low-volume metastatic seminoma.
A new risk stratification model can identify patients with stage I seminoma who have a high risk of relapse, according to researchers.
Incidence and mortality rates for major genitourinary cancers differ according to sex, race/ethnicity, and geographic region.
Exercise during chemotherapy may preserve cardiorespiratory fitness, a study suggests.
A new study suggests that previous use of cannabis is associated with a lower risk of certain genitourinary cancers.
Data suggest that 0.5% of patients with clinical stage I testicular cancer experience relapse after 10 years.
Modifiable adverse health outcomes affect overall mortality and cancer mortality in testicular cancer survivors.
Certain treatments were associated with an increased risk of death unrelated to testicular cancer.
Guideline-directed care resulted in equivalent outcomes independent of hospital setting.
A subset of testicular cancer survivors experience persistent, treatment-related, long-term adverse health outcomes that affect their ability to work.